Form 4: McKesson Corp Executive Sells Shares

Sentiment:

Statement of Changes in Beneficial Ownership


McKesson Corp's EVP & CFO, Britt J. Vitalone, reported a transaction involving the sale of company stock.

Summary

  • Britt J. Vitalone, EVP & CFO of McKesson Corp, engaged in a transaction on May 23, 2026.
  • This transaction involved the acquisition of 1,476 shares of common stock for $0, with a value of $22,534.377.
  • Additionally, 581 shares were disposed of for $766.08 per share, resulting in a value of $21,953.377.
  • Following these transactions, Vitalone beneficially owns 21,953.377 shares directly.
  • There are also 552.2562 shares held indirectly through the McKesson Corporation 401(k) Retirement Savings Plan.
  • Restricted Stock Units (RSUs) were also involved, with 1,476 RSUs vesting, which are tied to common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves a stock transaction by a key executive, the explanation clarifies it's a standard tax-related withholding upon RSU vesting, not an opportunistic sale.

Positives

  • The vesting of 1,476 Restricted Stock Units (RSUs) indicates continued equity compensation for the executive.
  • The executive retains a significant number of shares (21,953.377 directly and 552.2562 indirectly) after the reported transactions.

Negatives

  • The disposal of 581 shares for $766.08 each suggests a reduction in the executive's direct stock holding.
  • The transaction code 'M' for the acquisition of 1,476 shares at $0 price, and the explanation 'withholding of shares to cover taxes applicable to a vesting of RSUs', indicates these shares were used to satisfy tax obligations, not a net gain of shares.

Risks

  • The filing does not explicitly mention any new risks or challenges.
  • However, any executive stock sale can be perceived negatively by the market, potentially signaling a lack of confidence, though this is a tax-related withholding.

Future Outlook

The filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding future financial performance.

Management Comments

  • The explanation for the transaction states: 'This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4.'
  • Regarding RSUs: 'These RSUs vested as to 1/3 on 5/23/2024, 1/3 on 5/23/2025 and 1/3 on 5/23/2026.'

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The specific details of this transaction, particularly the share withholding for tax purposes related to RSU vesting, are common within the pharmaceutical distribution and healthcare services industry where equity-based compensation is prevalent.

Stakeholder Impact

  • Shareholders: The transaction is a routine tax event for the executive and is unlikely to have a significant direct impact on the share price, though any insider selling can be scrutinized.
  • Employees: The RSU vesting and tax withholding mechanism is a standard component of executive compensation, reflecting the company's compensation strategy.
  • Management: Demonstrates adherence to disclosure requirements regarding beneficial ownership changes.

Next Steps

  • No specific next steps are outlined in this filing beyond the reported transaction.

Key Dates

DateDescription
05/23/2026Earliest transaction date and transaction date for stock acquisition and RSU vesting.
05/27/2026Date of signature for the filing.

Keywords

McKesson Corp, MCK, Form 4, Insider Trading, Stock Transaction, Executive Compensation, Britt J. Vitalone, EVP & CFO, RSUs, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.